SWKH News and Press, SWK Holdings Corporation From 06/07/21

Enteris BioPharma to Participate in BIO Digital 2021 PR Newswire BOONTON, N.J. , June 7, 2021 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-ow...

SWK Holdings (SWKH): Q1 GAAP EPS of $0.26 misses by $0.13.Revenue of $9.37M (+28.4% Y/Y) beats by $0.99M.Shares +6.03% AH.Press Release For further details see: SWK Holdings EPS misses by $0.13, beats on revenue

SWK Holdings Corporation Announces Financial Results for First Quarter 2021 Conference Call and Live Audio Webcast Scheduled for Tuesday, May 18, 2021 at 10:00 a.m. ET PR Newswire DALLAS , May 17, 2021 /PRNewswire/ -- Corporate Updates YTD SWK h...

SWK Holdings and Carlson Capital L.P. Announce Board Changes, Formation of Strategic Review Committee and Update on Previously-Disclosed Non-Binding Proposal PR Newswire DALLAS , May 17, 2021 /PRNewswire/ -- The Board of Directors (the "Board") o...

Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds PR News...

SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P. PR Newswire DALLAS , April 6, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that on April 5, 2021 , a Special Committee (t...

SWK Holdings (SWKH): Q4 GAAP EPS of $0.36 beats by $0.10.Revenue of $10.9M (+16.0% Y/Y) misses by $0.59M.Press Release For further details see: SWK Holdings EPS beats by $0.10, misses on revenue

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2020 Specialty Finance Portfolio Growth, Underlying Credit Performance Highlight Strong 2020 Conference Call and Live Audio Webcast Scheduled for Thursday, April 1, 2021 at 10:00 a.m. ET ...

Acerus Pharmaceuticals ([[ASPCF]]) announces that it has entered into an amended agreement related to its existing credit facility with SWK Funding, a subsidiary of SWK Holdings Corporation ([[SWKH]] -2.1%).The amendments set principal repayment at $1.1M for May 15, 2021 followed by quarterly...

TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today announced that it has entered into an amended agreement related to its existing credit facility with SWK Funding LLC (“...